The Manufacturers Life Insurance Company Purchases 18,389 Shares of Billiontoone, Inc. $BLLN

The Manufacturers Life Insurance Company lifted its position in shares of Billiontoone, Inc. (NASDAQ:BLLN) by 151.8% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 30,506 shares of the company’s stock after purchasing an additional 18,389 shares during the period. The Manufacturers Life Insurance Company owned 0.07% of Billiontoone worth $2,408,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the business. Rossby Financial LCC bought a new position in Billiontoone during the 4th quarter valued at approximately $25,000. Wells Fargo & Company MN bought a new stake in shares of Billiontoone in the 4th quarter worth approximately $76,000. Smartleaf Asset Management LLC bought a new stake in shares of Billiontoone in the 4th quarter worth approximately $80,000. Nano Cap New Millennium Growth Fund L P purchased a new position in shares of Billiontoone during the fourth quarter valued at approximately $82,000. Finally, Renaissance Capital LLC bought a new position in shares of Billiontoone during the fourth quarter valued at approximately $201,000.

Analysts Set New Price Targets

Several research firms recently weighed in on BLLN. Weiss Ratings upgraded shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a report on Tuesday, June 23rd. BTIG Research dropped their target price on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating for the company in a research report on Thursday. JPMorgan Chase & Co. cut their target price on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a research note on Thursday. Guggenheim began coverage on shares of Billiontoone in a research report on Monday, June 29th. They set a “buy” rating and a $125.00 price target on the stock. Finally, Wall Street Zen downgraded shares of Billiontoone from a “buy” rating to a “hold” rating in a research note on Saturday. Six equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Billiontoone currently has an average rating of “Moderate Buy” and an average target price of $126.71.

Billiontoone Price Performance

Shares of BLLN stock opened at $93.39 on Friday. The stock has a market cap of $4.30 billion and a price-to-earnings ratio of 133.41. The business’s fifty day moving average is $116.49 and its 200 day moving average is $94.28. Billiontoone, Inc. has a twelve month low of $61.96 and a twelve month high of $150.44. The company has a quick ratio of 10.58, a current ratio of 11.69 and a debt-to-equity ratio of 0.17.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 EPS for the quarter, meeting the consensus estimate of $0.15. The business had revenue of $109.45 million during the quarter. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. Research analysts expect that Billiontoone, Inc. will post 0.92 EPS for the current fiscal year.

Insider Buying and Selling at Billiontoone

In other Billiontoone news, SVP Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock in a transaction on Monday, June 29th. The stock was sold at an average price of $120.00, for a total transaction of $169,920.00. Following the completion of the transaction, the senior vice president owned 33,552 shares in the company, valued at approximately $4,026,240. The trade was a 4.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Shan Riku Sakakibara sold 4,000 shares of the business’s stock in a transaction on Friday, July 31st. The stock was sold at an average price of $140.21, for a total value of $560,840.00. Following the completion of the sale, the insider directly owned 200,000 shares in the company, valued at $28,042,000. This trade represents a 1.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 202,049 shares of company stock worth $23,496,861 in the last ninety days. 50.22% of the stock is owned by company insiders.

Billiontoone Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.